المؤلفون: Jespersen CP; Research Clinic for Functional Disorders and Psychosomatics, Aarhus University Hospital, Aarhus, Denmark; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark. Electronic address: cecijesp@rm.dk., Pedersen HF; Research Clinic for Functional Disorders and Psychosomatics, Aarhus University Hospital, Aarhus, Denmark; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark., Kleinstäuber M; Department of Psychology, Emma Eccles Jones College of Education and Human Services, Utah State University, Logan, UT, USA., Fink P; Research Clinic for Functional Disorders and Psychosomatics, Aarhus University Hospital, Aarhus, Denmark; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark., Wellnitz KB; Research Clinic for Functional Disorders and Psychosomatics, Aarhus University Hospital, Aarhus, Denmark; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark., Ørnbøl E; Research Clinic for Functional Disorders and Psychosomatics, Aarhus University Hospital, Aarhus, Denmark; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark., Schröder A; Research Clinic for Functional Disorders and Psychosomatics, Aarhus University Hospital, Aarhus, Denmark., Agger JL; Research Clinic for Functional Disorders and Psychosomatics, Aarhus University Hospital, Aarhus, Denmark., Vase L; Department of Psychology and Behavioral Sciences, School of Business and Social Sciences, Aarhus University, Aarhus, Denmark., Finnerup NB; Danish Pain Research Center, Department of Clinical Medicine, Aarhus University, Aarhus, Denmark; Department of Neurology, Aarhus University Hospital, Aarhus, Denmark., Gormsen LK; Research Clinic for Functional Disorders and Psychosomatics, Aarhus University Hospital, Aarhus, Denmark; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.

المصدر: Contemporary clinical trials [Contemp Clin Trials] 2024 Jun; Vol. 141, pp. 107524. Date of Electronic Publication: 2024 Apr 09.

نوع المنشور: Clinical Trial Protocol; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 101242342 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1559-2030 (Electronic) Linking ISSN: 15517144 NLM ISO Abbreviation: Contemp Clin Trials Subsets: MEDLINE

مواضيع طبية MeSH: Depression*/drug therapy , Duloxetine Hydrochloride*/therapeutic use , Duloxetine Hydrochloride*/administration & dosage , Patient Education as Topic*/methods, Adult ; Female ; Humans ; Male ; Middle Aged ; Antidepressive Agents/therapeutic use ; Antidepressive Agents/administration & dosage ; Anxiety/drug therapy ; Combined Modality Therapy ; Quality of Life ; Randomized Controlled Trials as Topic

المؤلفون: Shao Y; Peking University Sixth Hospital, Peking University Institute of Mental Health, NHC Key Laboratory of Mental Health (Peking University), National Clinical Research Center for Mental Disorders (Peking University Sixth Hospital), Peking University, 51 Huayuan Bei Road, Haidian District, 100191, Beijing, China., Chen Y; Ordos Fourth People's Hospital, Ordos, China., Wang S; Peking University Sixth Hospital, Peking University Institute of Mental Health, NHC Key Laboratory of Mental Health (Peking University), National Clinical Research Center for Mental Disorders (Peking University Sixth Hospital), Peking University, 51 Huayuan Bei Road, Haidian District, 100191, Beijing, China., Li C; Peking University Sixth Hospital, Peking University Institute of Mental Health, NHC Key Laboratory of Mental Health (Peking University), National Clinical Research Center for Mental Disorders (Peking University Sixth Hospital), Peking University, 51 Huayuan Bei Road, Haidian District, 100191, Beijing, China., Sun H; Peking University Sixth Hospital, Peking University Institute of Mental Health, NHC Key Laboratory of Mental Health (Peking University), National Clinical Research Center for Mental Disorders (Peking University Sixth Hospital), Peking University, 51 Huayuan Bei Road, Haidian District, 100191, Beijing, China., Sun X; Peking University Sixth Hospital, Peking University Institute of Mental Health, NHC Key Laboratory of Mental Health (Peking University), National Clinical Research Center for Mental Disorders (Peking University Sixth Hospital), Peking University, 51 Huayuan Bei Road, Haidian District, 100191, Beijing, China. sunxinyu@bjmu.edu.cn.

المصدر: BMC psychiatry [BMC Psychiatry] 2024 May 10; Vol. 24 (1), pp. 349. Date of Electronic Publication: 2024 May 10.

نوع المنشور: Case Reports; Journal Article

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 100968559 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-244X (Electronic) Linking ISSN: 1471244X NLM ISO Abbreviation: BMC Psychiatry Subsets: MEDLINE

مواضيع طبية MeSH: Duloxetine Hydrochloride*/therapeutic use , Duloxetine Hydrochloride*/adverse effects , Restless Legs Syndrome*/drug therapy , Restless Legs Syndrome*/chemically induced , Pramipexole*/therapeutic use , Pramipexole*/adverse effects, Humans ; Female ; Aged ; Antidepressive Agents/adverse effects ; Antidepressive Agents/therapeutic use ; Phenotype ; Serotonin and Noradrenaline Reuptake Inhibitors/adverse effects ; Serotonin and Noradrenaline Reuptake Inhibitors/therapeutic use ; Citalopram/therapeutic use ; Citalopram/adverse effects

المؤلفون: Khalil SM; Center for Drug Discovery, Department of Pathology and Immunology (S.M.K., X.Q., J.M.H., Jia.W., M.M.-S., K.R.M., M.M.M., F.L.), NMR and Drug Metabolism Core, Advanced Technology Cores (X.Q., J.M.H., Jia.W., K.R.M., F.L.), Department of Biochemistry and Molecular Pharmacology (Jin.W., K.R.M., M.M.M., F.L.), Department of Pediatrics (S.M.K., M.M.-S.), and Nephrology Division, Department of Medicine (Z.H.), Baylor College of Medicine, Houston, Texas; Jan and Dan Duncan Neurologic Research Institute, Texas Children's Hospital, Houston, Texas (M.M.-S.); and Department of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston, Houston, Texas (X.L.)., Qin X; Center for Drug Discovery, Department of Pathology and Immunology (S.M.K., X.Q., J.M.H., Jia.W., M.M.-S., K.R.M., M.M.M., F.L.), NMR and Drug Metabolism Core, Advanced Technology Cores (X.Q., J.M.H., Jia.W., K.R.M., F.L.), Department of Biochemistry and Molecular Pharmacology (Jin.W., K.R.M., M.M.M., F.L.), Department of Pediatrics (S.M.K., M.M.-S.), and Nephrology Division, Department of Medicine (Z.H.), Baylor College of Medicine, Houston, Texas; Jan and Dan Duncan Neurologic Research Institute, Texas Children's Hospital, Houston, Texas (M.M.-S.); and Department of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston, Houston, Texas (X.L.)., Hakenjos JM; Center for Drug Discovery, Department of Pathology and Immunology (S.M.K., X.Q., J.M.H., Jia.W., M.M.-S., K.R.M., M.M.M., F.L.), NMR and Drug Metabolism Core, Advanced Technology Cores (X.Q., J.M.H., Jia.W., K.R.M., F.L.), Department of Biochemistry and Molecular Pharmacology (Jin.W., K.R.M., M.M.M., F.L.), Department of Pediatrics (S.M.K., M.M.-S.), and Nephrology Division, Department of Medicine (Z.H.), Baylor College of Medicine, Houston, Texas; Jan and Dan Duncan Neurologic Research Institute, Texas Children's Hospital, Houston, Texas (M.M.-S.); and Department of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston, Houston, Texas (X.L.)., Wang J; Center for Drug Discovery, Department of Pathology and Immunology (S.M.K., X.Q., J.M.H., Jia.W., M.M.-S., K.R.M., M.M.M., F.L.), NMR and Drug Metabolism Core, Advanced Technology Cores (X.Q., J.M.H., Jia.W., K.R.M., F.L.), Department of Biochemistry and Molecular Pharmacology (Jin.W., K.R.M., M.M.M., F.L.), Department of Pediatrics (S.M.K., M.M.-S.), and Nephrology Division, Department of Medicine (Z.H.), Baylor College of Medicine, Houston, Texas; Jan and Dan Duncan Neurologic Research Institute, Texas Children's Hospital, Houston, Texas (M.M.-S.); and Department of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston, Houston, Texas (X.L.)., Hu Z; Center for Drug Discovery, Department of Pathology and Immunology (S.M.K., X.Q., J.M.H., Jia.W., M.M.-S., K.R.M., M.M.M., F.L.), NMR and Drug Metabolism Core, Advanced Technology Cores (X.Q., J.M.H., Jia.W., K.R.M., F.L.), Department of Biochemistry and Molecular Pharmacology (Jin.W., K.R.M., M.M.M., F.L.), Department of Pediatrics (S.M.K., M.M.-S.), and Nephrology Division, Department of Medicine (Z.H.), Baylor College of Medicine, Houston, Texas; Jan and Dan Duncan Neurologic Research Institute, Texas Children's Hospital, Houston, Texas (M.M.-S.); and Department of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston, Houston, Texas (X.L.)., Liu X; Center for Drug Discovery, Department of Pathology and Immunology (S.M.K., X.Q., J.M.H., Jia.W., M.M.-S., K.R.M., M.M.M., F.L.), NMR and Drug Metabolism Core, Advanced Technology Cores (X.Q., J.M.H., Jia.W., K.R.M., F.L.), Department of Biochemistry and Molecular Pharmacology (Jin.W., K.R.M., M.M.M., F.L.), Department of Pediatrics (S.M.K., M.M.-S.), and Nephrology Division, Department of Medicine (Z.H.), Baylor College of Medicine, Houston, Texas; Jan and Dan Duncan Neurologic Research Institute, Texas Children's Hospital, Houston, Texas (M.M.-S.); and Department of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston, Houston, Texas (X.L.)., Wang J; Center for Drug Discovery, Department of Pathology and Immunology (S.M.K., X.Q., J.M.H., Jia.W., M.M.-S., K.R.M., M.M.M., F.L.), NMR and Drug Metabolism Core, Advanced Technology Cores (X.Q., J.M.H., Jia.W., K.R.M., F.L.), Department of Biochemistry and Molecular Pharmacology (Jin.W., K.R.M., M.M.M., F.L.), Department of Pediatrics (S.M.K., M.M.-S.), and Nephrology Division, Department of Medicine (Z.H.), Baylor College of Medicine, Houston, Texas; Jan and Dan Duncan Neurologic Research Institute, Texas Children's Hospital, Houston, Texas (M.M.-S.); and Department of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston, Houston, Texas (X.L.)., Maletic-Savatic M; Center for Drug Discovery, Department of Pathology and Immunology (S.M.K., X.Q., J.M.H., Jia.W., M.M.-S., K.R.M., M.M.M., F.L.), NMR and Drug Metabolism Core, Advanced Technology Cores (X.Q., J.M.H., Jia.W., K.R.M., F.L.), Department of Biochemistry and Molecular Pharmacology (Jin.W., K.R.M., M.M.M., F.L.), Department of Pediatrics (S.M.K., M.M.-S.), and Nephrology Division, Department of Medicine (Z.H.), Baylor College of Medicine, Houston, Texas; Jan and Dan Duncan Neurologic Research Institute, Texas Children's Hospital, Houston, Texas (M.M.-S.); and Department of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston, Houston, Texas (X.L.)., MacKenzie KR; Center for Drug Discovery, Department of Pathology and Immunology (S.M.K., X.Q., J.M.H., Jia.W., M.M.-S., K.R.M., M.M.M., F.L.), NMR and Drug Metabolism Core, Advanced Technology Cores (X.Q., J.M.H., Jia.W., K.R.M., F.L.), Department of Biochemistry and Molecular Pharmacology (Jin.W., K.R.M., M.M.M., F.L.), Department of Pediatrics (S.M.K., M.M.-S.), and Nephrology Division, Department of Medicine (Z.H.), Baylor College of Medicine, Houston, Texas; Jan and Dan Duncan Neurologic Research Institute, Texas Children's Hospital, Houston, Texas (M.M.-S.); and Department of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston, Houston, Texas (X.L.)., Matzuk MM; Center for Drug Discovery, Department of Pathology and Immunology (S.M.K., X.Q., J.M.H., Jia.W., M.M.-S., K.R.M., M.M.M., F.L.), NMR and Drug Metabolism Core, Advanced Technology Cores (X.Q., J.M.H., Jia.W., K.R.M., F.L.), Department of Biochemistry and Molecular Pharmacology (Jin.W., K.R.M., M.M.M., F.L.), Department of Pediatrics (S.M.K., M.M.-S.), and Nephrology Division, Department of Medicine (Z.H.), Baylor College of Medicine, Houston, Texas; Jan and Dan Duncan Neurologic Research Institute, Texas Children's Hospital, Houston, Texas (M.M.-S.); and Department of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston, Houston, Texas (X.L.)., Li F; Center for Drug Discovery, Department of Pathology and Immunology (S.M.K., X.Q., J.M.H., Jia.W., M.M.-S., K.R.M., M.M.M., F.L.), NMR and Drug Metabolism Core, Advanced Technology Cores (X.Q., J.M.H., Jia.W., K.R.M., F.L.), Department of Biochemistry and Molecular Pharmacology (Jin.W., K.R.M., M.M.M., F.L.), Department of Pediatrics (S.M.K., M.M.-S.), and Nephrology Division, Department of Medicine (Z.H.), Baylor College of Medicine, Houston, Texas; Jan and Dan Duncan Neurologic Research Institute, Texas Children's Hospital, Houston, Texas (M.M.-S.); and Department of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston, Houston, Texas (X.L.) fl3@bcm.edu.

المصدر: Drug metabolism and disposition: the biological fate of chemicals [Drug Metab Dispos] 2024 Jun 17; Vol. 52 (7), pp. 673-680. Date of Electronic Publication: 2024 Jun 17.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Society for Pharmacology and Experimental Therapeutics, etc.] Country of Publication: United States NLM ID: 9421550 Publication Model: Electronic Cited Medium: Internet ISSN: 1521-009X (Electronic) Linking ISSN: 00909556 NLM ISO Abbreviation: Drug Metab Dispos Subsets: MEDLINE

مواضيع طبية MeSH: Duloxetine Hydrochloride*/metabolism , Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization*/methods , Spleen*/metabolism , Spleen*/drug effects , Brain*/metabolism , Brain*/drug effects , Brain*/diagnostic imaging , Kidney*/metabolism , Kidney*/drug effects , Liver*/metabolism , Liver*/drug effects , Antidepressive Agents*/metabolism, Animals ; Mice ; Tissue Distribution ; Male ; Mice, Inbred C57BL

المؤلفون: Gao W; Affiliated Psychological Hospital of Anhui Medical University, Hefei, China.; Department of Pharmacy, Hefei Fourth People's Hospital, Hefei, China.; Psychopharmacology Research Laboratory, Anhui Mental Health Center, Hefei, China.; Anhui Clinical Research Center for Mental Disorders, Hefei, China., Gao Y; School of Pharmacy, Anhui Medical University, 81 Meishan Road, Hefei, 230000, PR China.; Department of Science and Education, Affiliated Psychological Hospital of Anhui Medical University, Hefei, China., Xu Y; Affiliated Psychological Hospital of Anhui Medical University, Hefei, China.; Department of Pharmacy, Hefei Fourth People's Hospital, Hefei, China.; Psychopharmacology Research Laboratory, Anhui Mental Health Center, Hefei, China.; Anhui Clinical Research Center for Mental Disorders, Hefei, China., Liang J; Affiliated Psychological Hospital of Anhui Medical University, Hefei, China.; Department of Pharmacy, Hefei Fourth People's Hospital, Hefei, China.; Psychopharmacology Research Laboratory, Anhui Mental Health Center, Hefei, China.; Anhui Clinical Research Center for Mental Disorders, Hefei, China., Sun Y; Affiliated Psychological Hospital of Anhui Medical University, Hefei, China.; Department of Pharmacy, Hefei Fourth People's Hospital, Hefei, China.; Psychopharmacology Research Laboratory, Anhui Mental Health Center, Hefei, China.; Anhui Clinical Research Center for Mental Disorders, Hefei, China., Zhang Y; Affiliated Psychological Hospital of Anhui Medical University, Hefei, China.; Department of Pharmacy, Hefei Fourth People's Hospital, Hefei, China.; Psychopharmacology Research Laboratory, Anhui Mental Health Center, Hefei, China.; Anhui Clinical Research Center for Mental Disorders, Hefei, China., Shan F; Affiliated Psychological Hospital of Anhui Medical University, Hefei, China.; Department of Pharmacy, Hefei Fourth People's Hospital, Hefei, China.; Psychopharmacology Research Laboratory, Anhui Mental Health Center, Hefei, China.; Anhui Clinical Research Center for Mental Disorders, Hefei, China., Ge J; Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Anhui Institute of Innovative Drugs, Anhui Medical University, Hefei, China. gejinfang@ahmu.edu.cn.; The Key Laboratory of Anti-inflammatory and Immune Medicines, Ministry of Education, Hefei, China. gejinfang@ahmu.edu.cn.; School of Pharmacy, Anhui Medical University, 81 Meishan Road, Hefei, 230000, PR China. gejinfang@ahmu.edu.cn., Xia Q; School of Pharmacy, Anhui Medical University, 81 Meishan Road, Hefei, 230000, PR China. ahmcxqr@163.com.; Department of Science and Education, Affiliated Psychological Hospital of Anhui Medical University, Hefei, China. ahmcxqr@163.com.

المصدر: BMC psychiatry [BMC Psychiatry] 2024 Jun 14; Vol. 24 (1), pp. 449. Date of Electronic Publication: 2024 Jun 14.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 100968559 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-244X (Electronic) Linking ISSN: 1471244X NLM ISO Abbreviation: BMC Psychiatry Subsets: MEDLINE

مواضيع طبية MeSH: Duloxetine Hydrochloride*/therapeutic use , Depressive Disorder, Major*/drug therapy , Depressive Disorder, Major*/blood , Cytokines*/blood, Humans ; Female ; Male ; Adult ; Middle Aged ; Antidepressive Agents/therapeutic use ; Case-Control Studies ; Inflammation/blood ; Inflammation/drug therapy

المؤلفون: Abdallah AMA; Departments of Oral and Maxillofacial Surgery., El Fadly MAEA; Departments of Oral and Maxillofacial Surgery., Abdelfateh SMG; Anaesthesia, Surgical Intensive Care, and Pain Management, Faculty of Dentistry, Ain Shams University, Cairo, Egypt., Taha MMS; Departments of Oral and Maxillofacial Surgery.

المصدر: The Journal of craniofacial surgery [J Craniofac Surg] 2024 Jun 01; Vol. 35 (4), pp. 1236-1240. Date of Electronic Publication: 2024 May 10.

نوع المنشور: Journal Article; Randomized Controlled Trial

بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 9010410 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1536-3732 (Electronic) Linking ISSN: 10492275 NLM ISO Abbreviation: J Craniofac Surg Subsets: MEDLINE

مواضيع طبية MeSH: Duloxetine Hydrochloride*/therapeutic use , Temporomandibular Joint Disorders*/drug therapy , Temporomandibular Joint Disorders*/surgery , Arthrocentesis*/methods , Pain Measurement*, Humans ; Female ; Male ; Adult ; Treatment Outcome ; Combined Modality Therapy ; Middle Aged ; Anxiety ; Depression ; Chronic Pain/drug therapy ; Serotonin and Noradrenaline Reuptake Inhibitors/therapeutic use ; Serotonin and Noradrenaline Reuptake Inhibitors/administration & dosage

المؤلفون: Ang DC; Department of Medicine/Rheumatology, Wake Forest University School of Medicine, Winston Salem, NC, 27157, USA. dang@wakehealth.edu., Davuluri S; Department of Psychiatry and Behavioral Medicine, Wake Forest University School of Medicine, Winston Salem, NC, USA., Kaplan S; Department of Psychiatry and Behavioral Medicine, Wake Forest University School of Medicine, Winston Salem, NC, USA., Keefe F; Department of Psychiatry and Behavioral Sciences, Duke University, Durham, NC, USA., Rini C; Department of Medical Social Sciences, Northwestern University, Chicago, IL, USA., Miles C; Department of Family Medicine, Wake Forest University School of Medicine, Winston Salem, NC, USA., Chen H; Department of Biostatistical Sciences, Wake Forest University, Winston Salem, NC, USA.

المصدر: Trials [Trials] 2024 May 18; Vol. 25 (1), pp. 330. Date of Electronic Publication: 2024 May 18.

نوع المنشور: Journal Article; Clinical Trial Protocol

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 101263253 Publication Model: Electronic Cited Medium: Internet ISSN: 1745-6215 (Electronic) Linking ISSN: 17456215 NLM ISO Abbreviation: Trials Subsets: MEDLINE

مواضيع طبية MeSH: Duloxetine Hydrochloride*/therapeutic use , Cognitive Behavioral Therapy*/methods , Chronic Pain*/therapy , Chronic Pain*/drug therapy , Chronic Pain*/psychology , Musculoskeletal Pain*/therapy , Musculoskeletal Pain*/psychology , Musculoskeletal Pain*/drug therapy , Musculoskeletal Pain*/diagnosis , Randomized Controlled Trials as Topic*, Humans ; Treatment Outcome ; Combined Modality Therapy ; Pain Measurement ; Telephone ; Motivational Interviewing ; Analgesics/therapeutic use ; Time Factors ; Internet-Based Intervention ; Pain Management/methods ; Adaptation, Psychological ; Adult

المؤلفون: Ding H; Department of Pharmacology, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, 1 Xian Nong Tan Street, Beijing 100050, China., Wang Y; Department of Pharmacology, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, 1 Xian Nong Tan Street, Beijing 100050, China., Gao Y; Department of Pharmacology, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, 1 Xian Nong Tan Street, Beijing 100050, China., Ye F; Department of Pharmacology, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, 1 Xian Nong Tan Street, Beijing 100050, China., Yao K; Department of Pharmacology, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, 1 Xian Nong Tan Street, Beijing 100050, China., Cao L; Department of Pharmacology, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, 1 Xian Nong Tan Street, Beijing 100050, China., Liu Z; Department of Pharmacology, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, 1 Xian Nong Tan Street, Beijing 100050, China., Wang G; Department of Pharmacology, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, 1 Xian Nong Tan Street, Beijing 100050, China; State Key Laboratory of Digestive Health, Beijing, China. Electronic address: guibinwang@imm.ac.cn., Zhang J; Department of Pharmacology, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, 1 Xian Nong Tan Street, Beijing 100050, China; State Key Laboratory of Digestive Health, Beijing, China. Electronic address: jjzhang@imm.ac.cn.

المصدر: Toxicology and applied pharmacology [Toxicol Appl Pharmacol] 2024 May; Vol. 486, pp. 116950. Date of Electronic Publication: 2024 May 01.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Academic Press Country of Publication: United States NLM ID: 0416575 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-0333 (Electronic) Linking ISSN: 0041008X NLM ISO Abbreviation: Toxicol Appl Pharmacol Subsets: MEDLINE

مواضيع طبية MeSH: Duloxetine Hydrochloride*/pharmacology , Gastric Mucosa*/drug effects , Gastric Mucosa*/pathology , Gastric Mucosa*/metabolism , Indomethacin*/toxicity , Proto-Oncogene Proteins c-akt*/metabolism , Chemokine CCL5*/metabolism , Signal Transduction*/drug effects , Vascular Endothelial Growth Factor A*/metabolism , Rats, Sprague-Dawley* , Stomach Ulcer*/chemically induced , Stomach Ulcer*/prevention & control , Stomach Ulcer*/pathology , Stomach Ulcer*/metabolism , Serotonin*/metabolism, Animals ; Male ; Rats ; Phosphatidylinositol 3-Kinases/metabolism

المؤلفون: Yalçınkaya B; Department of Physical and Rehabilitation Medicine, Hacettepe University Medical School, Ankara, Turkey., Tüten B; Department of Physical and Rehabilitation Medicine, Hacettepe University Medical School, Ankara, Turkey., Yazar B; Department of Physical and Rehabilitation Medicine, Hacettepe University Medical School, Ankara, Turkey., Demirel K; Department of Physical and Rehabilitation Medicine, Hacettepe University Medical School, Ankara, Turkey., Ocak H; Department of Physical and Rehabilitation Medicine, Hacettepe University Medical School, Ankara, Turkey.

المصدر: Pain practice : the official journal of World Institute of Pain [Pain Pract] 2024 Jan; Vol. 24 (1), pp. 237. Date of Electronic Publication: 2023 Aug 01.

نوع المنشور: Letter

بيانات الدورية: Publisher: Blackwell Science, Inc Country of Publication: United States NLM ID: 101130835 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1533-2500 (Electronic) Linking ISSN: 15307085 NLM ISO Abbreviation: Pain Pract Subsets: MEDLINE

مواضيع طبية MeSH: Duloxetine Hydrochloride*/adverse effects , Tachycardia*/chemically induced, Humans

المؤلفون: Shibata RY; Clinical Pharmacology & Pharmacokinetics, Project Management Dept, Shionogi & Co, Ltd, Osaka, Japan., Kubota R; Clinical Pharmacology & Pharmacokinetics, Project Management Dept, Shionogi & Co, Ltd, Osaka, Japan. Electronic address: ryuji.kubota@shionogi.co.jp., Uenaka K; Pharmacokinetics/Pharmacodynamics & Pharmacometrics, Japan Drug Development & Medical Affairs, Eli Lilly Japan K.K, Kobe, Japan., Kaibara A; Pharmacokinetics/Pharmacodynamics & Pharmacometrics, Japan Drug Development & Medical Affairs, Eli Lilly Japan K.K, Kobe, Japan., Wajima T; Clinical Pharmacology & Pharmacokinetics, Project Management Dept, Shionogi & Co, Ltd, Osaka, Japan.

المصدر: Drug metabolism and pharmacokinetics [Drug Metab Pharmacokinet] 2023 Aug; Vol. 51, pp. 100496. Date of Electronic Publication: 2023 Feb 15.

نوع المنشور: Clinical Trial, Phase III; Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 101164773 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1880-0920 (Electronic) Linking ISSN: 13474367 NLM ISO Abbreviation: Drug Metab Pharmacokinet Subsets: MEDLINE

مواضيع طبية MeSH: Depressive Disorder, Major*/drug therapy , Duloxetine Hydrochloride*/pharmacokinetics, Adult ; Child ; Humans ; East Asian People ; Japan

المؤلفون: Tabei SS; Division of Urology, Department of Surgery, University of Cincinnati College of Medicine, 231 Albert Sabin Way, Cincinnati, OH, 45267, USA., Baas W; Division of Urology, Department of Surgery, University of Cincinnati College of Medicine, 231 Albert Sabin Way, Cincinnati, OH, 45267, USA., Mahdy A; Division of Urology, Department of Surgery, University of Cincinnati College of Medicine, 231 Albert Sabin Way, Cincinnati, OH, 45267, USA. mahdyan@uc.edu.; R. Bruce and Barbara Bracken Endowed Chair in Surgical Urology, Department of Surgery, University of Cincinnati College of Medicine, 231 Albert Sabin Way, ML 0589, Cincinnati, OH, 45267, USA. mahdyan@uc.edu.

المصدر: Current urology reports [Curr Urol Rep] 2024 Jul; Vol. 25 (7), pp. 141-148. Date of Electronic Publication: 2024 May 10.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Current Science Country of Publication: United States NLM ID: 100900943 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1534-6285 (Electronic) Linking ISSN: 15272737 NLM ISO Abbreviation: Curr Urol Rep Subsets: MEDLINE

مواضيع طبية MeSH: Urinary Incontinence, Stress*/drug therapy, Humans ; Duloxetine Hydrochloride/therapeutic use ; Female ; Male